Acute events in children with sickle cell disease in Italy during the COVID-19 pandemic: useful lessons learned
- PMID: 34036565
- PMCID: PMC8239759
- DOI: 10.1111/bjh.17546
Acute events in children with sickle cell disease in Italy during the COVID-19 pandemic: useful lessons learned
Keywords: COVID-19; Italy; Vaso-occlusive crisis; acute chest; children; sickle cell disease.
Figures


Similar articles
-
Comparison of in-hospital mortality in children and adolescents with sickle cell disease in a resource-limited setting before and during the COVID-19 pandemic.Arch Pediatr. 2024 Jan;31(1):38-43. doi: 10.1016/j.arcped.2023.10.001. Epub 2023 Nov 21. Arch Pediatr. 2024. PMID: 37989661
-
The risk of acute events among patients with sickle cell disease in relation to early or late initiation of care at a specialist center: evidence from a retrospective cohort study.BMC Pediatr. 2020 Aug 8;20(1):373. doi: 10.1186/s12887-020-02270-y. BMC Pediatr. 2020. PMID: 32770992 Free PMC article.
-
Score Predicting Acute Chest Syndrome During Vaso-occlusive Crises in Adult Sickle-cell Disease Patients.EBioMedicine. 2016 Aug;10:305-11. doi: 10.1016/j.ebiom.2016.06.038. Epub 2016 Jun 29. EBioMedicine. 2016. PMID: 27412264 Free PMC article.
-
Managing Acute Complications Of Sickle Cell Disease In Pediatric Patients.Pediatr Emerg Med Pract. 2016 Nov;13(11):1-28. Epub 2016 Nov 2. Pediatr Emerg Med Pract. 2016. PMID: 27775898 Review.
-
The intersection between asthma and acute chest syndrome in children with sickle-cell anaemia.Lancet. 2016 Jun 18;387(10037):2545-53. doi: 10.1016/S0140-6736(16)00145-8. Lancet. 2016. PMID: 27353685 Free PMC article. Review.
Cited by
-
Impact of COVID-19 on incidence, clinical presentation, and prognosis of acute chest syndrome in patients with sickle cell disease.EJHaem. 2023 Oct 2;4(4):970-976. doi: 10.1002/jha2.768. eCollection 2023 Nov. EJHaem. 2023. PMID: 38024591 Free PMC article.
-
Incidence and predictors of priapism events in sickle cell anemia: a diary-based analysis.Blood Adv. 2022 Oct 25;6(20):5676-5683. doi: 10.1182/bloodadvances.2022007285. Blood Adv. 2022. PMID: 35816639 Free PMC article.
-
COVID- 19 in patients affected by red blood cell disorders, results from the European registry ERN-EuroBloodNet.Orphanet J Rare Dis. 2025 Apr 16;20(1):183. doi: 10.1186/s13023-025-03683-7. Orphanet J Rare Dis. 2025. PMID: 40241127 Free PMC article.
-
Absence of blood donors' anti-SARS-CoV-2 antibodies in pre-storage leukoreduced red blood cell units indicates no role of passive immunity for blood recipients.Ann Hematol. 2024 Feb;103(2):623-629. doi: 10.1007/s00277-023-05473-2. Epub 2023 Sep 27. Ann Hematol. 2024. PMID: 37758964 Free PMC article.
References
-
- Megna R. First month of the epidemic caused by COVID‐19 in Italy: current status and real‐time outbreak development forecast. Glob Health Res Policy. 2020;5:43;eCollection 2020. https://ghrp.biomedcentral.com/articles/10.1186/s41256‐020‐00170‐3 - DOI - PMC - PubMed
-
- Colombatti R, Palazzi G, Masera N, Notarangelo LD, Bonetti E, Samperi P, et al. Hydroxyurea prescription, availability and use for children with sickle cell disease in Italy: results of a National Multicenter survey. Pediatr Blood Cancer. 2018;65:e26774 - PubMed
-
- Piel FB, Steinberg MH, Rees DC. Sickle cell disease. N Engl J Med. 2017;376:1561–73. - PubMed
-
- Po’ C, Colombatti R, Cirigliano A, Dalt LD, Agosto C, Benini F, et al. The management of sickle cell pain in the emergency department: a priority for health systems. Clin J Pain. 2013;29:60–3. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical